Skip to main content

Marketing Authorization Holder (MAH)

LK-Unique ยท Full cradle-to-grave regulatory accountability

What Is an MAH?โ€‹

The Marketing Authorization Holder (MAH) is a Sri Lanka-based entity โ€” company or individual โ€” that is formally responsible to the NMRA for every aspect of a medical device's regulatory status in Sri Lanka. This role has broader accountability than a typical local representative or distributor.

Scope of MAH Responsibilityโ€‹

The MAH's accountability spans the full device lifecycle:

Lifecycle StageMAH Obligation
Pre-registrationArrange manufacturing site registration with NMRA
RegistrationSubmit Consolidated Dossier; manage NMRA queries; hold Registration Certificate
Import licensingApply for and hold Import Licence
Quality failuresReceive complaints; investigate with manufacturer; report to NMRA
VigilanceReport adverse events to NMRA within required timeframes
FSCAsInitiate, coordinate, and report FSCAs
AdvertisingObtain prior NMRA written approval for all device advertising
FeesPay annual NMRA maintenance fees
RenewalRenew Registration Certificates and Import Licences before expiry
ChangesNotify NMRA of post-approval changes
DistributionOversee and manage Sri Lankan supply chain
NMRA cooperationAssist inspections and provide records on request

Who Can Be an MAH?โ€‹

Any Sri Lanka-based entity (company or individual) with:

  • Valid Sri Lanka business registration
  • Sufficient technical and administrative capacity to fulfil MAH obligations
  • Ability to maintain required records and communications

Common MAH arrangements:

  • Local distributor acting as MAH
  • Dedicated regulatory affairs company
  • Locally registered subsidiary of the foreign manufacturer

MAH vs Importerโ€‹

The MAH holds the regulatory approvals. The actual physical importation and distribution may be handled by the MAH directly or by appointed importers and distributors. The MAH retains regulatory accountability regardless of who handles logistics.

Selecting an MAHโ€‹

Given the extensive obligations, manufacturers should carefully evaluate potential MAHs on:

  • Regulatory affairs experience and NMRA relationships
  • Technical understanding of the device category
  • Financial stability (annual fees are payable by the MAH)
  • Distribution capacity and network
  • Track record with NMRA submissions and post-market compliance

Good Distribution Practice (GDP) โ€” LK-Uniqueโ€‹

The NMRA has expectations regarding Good Distribution Practice of Medical Devices (GDPMD) โ€” standards for how registered devices are stored, transported, and distributed. The MAH is responsible for ensuring distribution activities comply with GDPMD requirements.

Currently, NMRA expectations are broadly aligned with WHO guidance on GDPMD. Anticipated formalisation of GDPMD requirements will introduce more explicit standards. The MAH should maintain:

  • Appropriate storage conditions (temperature, humidity as required for the device)
  • Traceability of device movements through the supply chain
  • Qualified personnel for distribution activities
  • Distribution records enabling device recall if required

Price Regulation โ€” LK-Unique NMRA USD Rate Scheduleโ€‹

The NMRA publishes a USD-denominated fee schedule for annual registration maintenance. The applicable exchange rate is updated monthly on the NMRA website. MAHs must:

  • Monitor the monthly rate
  • Calculate fees at the applicable rate for the payment month
  • Pay in Sri Lankan Rupees at the converted amount

Confirm the current fee schedule and payment process with the NMRA before making any payment.